Pacira BioSciences (PCRX) EPS (Diluted) (2010 - 2026)
Pacira BioSciences (PCRX) recorded EPS (Diluted) of $0.12 in Q2 2026, compared with -$0.11 a year earlier and up 62.0% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EPS (Diluted) (2010 - 2026) Analysis & Trends
On a TTM basis, Pacira BioSciences' EPS (Diluted) came in at $0.36 as of Jun 30, 2026; for FY2025, it was $0.16.
- Annual EPS (Diluted) has a five-year compound annual growth rate of -45.8% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at -$2.15 in FY2024, $0.81 in FY2023 (+136.1%), $0.34 in FY2022 (-62.8%) and $0.92 in FY2021 (-72.4%).
- Quarterly EPS (Diluted) has ranged from -$3.11 in Q3 2024 to $0.49 in Q2 2023 over the past five years.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 30.7% in Q2 2023, against a decline of 89.5% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $0.07 (Q1 2026), $0.04 (Q4 2025) and $0.12 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | -3.11 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.49 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | 0.39 |
API Access
Pacira BioSciences EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();